Literature DB >> 2322023

Association between HLA-DR antigens and rheumatoid arthritis in Arabs.

M A Sattar1, M al-Saffar, R T Guindi, T N Sugathan, K Behbehani.   

Abstract

Eighty five Arab patients with classical and definite rheumatoid arthritis were typed to determine the prevalence of HLA A, B, C, and DR antigens. A significant increase in the prevalence of HLA-A10, B8, B21, and DR3 was found in comparison with a control population matched for age and sex. HLA-DR5 was significantly decreased in the patient group. The classical association of HLA-DR4 with rheumatoid arthritis could not be confirmed in the Arab patients resident in Kuwait, supporting reported observations in different ethnic groups of associations with HLA antigens other than HLA-DR4 and indicating a heterogeneous genetic susceptibility to rheumatoid arthritis.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2322023      PMCID： PMC1004008          DOI： 10.1136/ard.49.3.147

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  18 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  B-lymphocyte alloantigens associated with systemic lupus erythematosus.

Authors:  J L Reinertsen; J H Klippel; A H Johnson; A D Steinberg; J L Decker; D L Mann
Journal:  N Engl J Med       Date:  1978-09-07       Impact factor: 91.245

3.  HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease.

Authors:  F C Grumet; R O Payne; J Konishi; J P Kriss
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

4.  Increased prevalence of DRw3 in the CREST syndrome.

Authors:  B F Germain; L R Espinoza; L L Bergen; M Vagesh; F B Vasey
Journal:  Arthritis Rheum       Date:  1981-06

5.  HLA antigens in Mexican patients with adult rheumatoid arthritis.

Authors:  C Gorodezky; C Lavalle; L E Castro-Escobar; J M Miranda-Limon; A Escobar-Gutierrez
Journal:  Arthritis Rheum       Date:  1981-07

6.  Association of the B-cell alloantigen DRw4 with rheumatoid arthritis.

Authors:  P Stastny
Journal:  N Engl J Med       Date:  1978-04-20       Impact factor: 91.245

7.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.

Authors:  G S Panayi; P Wooley; J R Batchelor
Journal:  Br Med J       Date:  1978-11-11

8.  Association of HLA-DRw4 with rheumatoid arthritis in black and white patients.

Authors:  R W Karr; G E Rodey; T Lee; B D Schwartz
Journal:  Arthritis Rheum       Date:  1980-11

9.  HLA and rheumatoid arthritis in the Japanese.

Authors:  Y Nakai; A Wakisaka; M Aizawa; K Itakura; H Nakai; A Ohashi
Journal:  Arthritis Rheum       Date:  1981-05

10.  The HLA system and disease. The Oliver Sharpey Lecture 1979.

Authors:  W F Bodmer
Journal:  J R Coll Physicians Lond       Date:  1980-01
View more
  5 in total

1.  Rheumatoid arthritis in a population sample in the Gulf: clinical observations.

Authors:  H M al Attia; O B Gatee; S George; M M Masri
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

2.  HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis.

Authors:  D S Bradley; G H Nabozny; S Cheng; P Zhou; M M Griffiths; H S Luthra; C S David
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

3.  Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis.

Authors:  E Zanelli; C J Krco; J M Baisch; S Cheng; C S David
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

4.  HLA-DRB1 association in Saudi rheumatoid arthritis patients.

Authors:  Ramiz Al-Swailem; Hannan Al-Rayes; Samia Sobki; Misbahul Arfin; Mohammad Tariq
Journal:  Rheumatol Int       Date:  2006-05-04       Impact factor: 2.631

5.  Safety, Tolerability, and Efficacy of Tocilizumab in Rheumatoid Arthritis: An Open-Label Phase 4 Study in Patients from the Middle East.

Authors:  Mohammed Hammoudeh; Adel Al Awadhi; Eman Haji Hasan; Maassoumeh Akhlaghi; Arman Ahmadzadeh; Bahar Sadeghi Abdollahi
Journal:  Int J Rheumatol       Date:  2015-05-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.